---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021772"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T20:57:20.420423+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Reports Q3 2025 Revenue of $7.5M, Net Loss $6.5M; Guides Q4 Revenue Above $9M

## Summary
- Q3 2025 revenue totaled $7.5M, with system revenue of $1.9M and recurring revenue of $5.6M.
- Net loss was $6.5M; adjusted net loss excluding non-cash charges was $2.4M.
- Cash and equivalents were $10.5M with no debt; additional $4M expected from July financing.
- FDA clearance for GenesisX robotic system announced; MAGiC Sweep generated over $300k in first two months.
- Q4 2025 revenue expected to exceed $9M, supporting annual revenue growth of over 20%.

## SEC filing metadata
- accession: 0001493152-25-021772
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315225021772/0001493152-25-021772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315225021772/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021772
- JSON: https://secwatch.observer/filing/0001493152-25-021772.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021772.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.